Accessibility Menu
 
Alzex Neuropharma logo

Alzex Neuropharma

(OTC) TRRI

Current Price$0.00
Market Cap$500
Since IPO (2008)-100%
5 Year-99%
1 Year-100%
1 Month+50%

Alzex Neuropharma Financials at a Glance

Market Cap

$500

Revenue (TTM)

$0.00

Net Income (TTM)

$254.12K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

2.52 (High)

Price

$0.00

Volume

113

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.08

TRRI News

No articles available.

TRRI: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Alzex Neuropharma

Industry

Metals and Mining

Sector

Materials

CEO

Robert W. Rosner

Headquarters

Las Vegas, NV 89052, US

TRRI Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

75%

Return on Assets

-8%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$500.00

Shares Outstanding

1.51M

Volume

113

Short Interest

0.00%

Avg. Volume

109.839

Financials (TTM)

Gross Profit

$0.00

Operating Income

$163.49K

EBITDA

$163.49K

Operating Cash Flow

$88.20K

Capital Expenditure

$0.00

Free Cash Flow

$88.20K

Cash & ST Invst.

$1.02K

Total Debt

$91.20K

Alzex Neuropharma Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2024YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$500.00

N/A

Market Cap/Employee

$45.45

N/A

Employees

11

N/A

Net Income

$85.58K

-99.0%

EBITDA

$83.68K

-804.3%

Quarterly Fundamentals

Name
Q2 2024YOY CHG

Net Cash

$116.96K

-29.7%

Accounts Receivable

$6.46K

-51.2%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$117.12K

+28.4%

Return on Assets

-8.45%

N/A

Return on Invested Capital

74.97%

N/A

Free Cash Flow

$3.59K

+94.0%

Operating Cash Flow

$3.59K

+94.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
RKTEReflectkote, Inc.
$0.00+0.00%
GPLDFGreat Panther Mining Limited
$0.00-90.00%
ASKEAlaska Pacific Energy Corp.
$0.00+0.00%
GRENGreensmart Corp
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$38.78-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$8.28+0.05%
QQQInvesco QQQ Trust
$562.58-0.02%
ARTLArtelo Biosciences
$10.54+2.30%

Questions About TRRI

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.